NEW YORK (GenomeWeb News) – When President Barack Obama included over $1 billion in the federal stimulus spending bill in February to study which healthcare treatments are most beneficial for most patients and most cost-effective, he signaled that comparative effectiveness research likely will be part of his administration's effort to change the healthcare system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.